MetLife Investment Management’s Dermira, Inc. DERM Stock Holding History

MetLife Investment Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,590	Closed	-$327K	–	2352
2019 Q4	$327K	Sell	21,590 -7,207	-25%	-$62.2K	﹤0.01%	1691
2019 Q3	$184K	Hold	28,797	–	–	﹤0.01%	1999
2019 Q2	$275K	Buy	28,797 +10,658	+59%	+$115K	﹤0.01%	1841
2019 Q1	$246K	Hold	18,139	–	–	﹤0.01%	1865
2018 Q4	$130K	Hold	18,139	–	–	﹤0.01%	2159
2018 Q3	$198K	Hold	18,139	–	–	﹤0.01%	2088
2018 Q2	$167K	Hold	18,139	–	–	﹤0.01%	2005
2018 Q1	$145K	Hold	18,139	–	–	﹤0.01%	2053
2017 Q4	$504K	Buy	+18,139	New	+$481K	0.01%	1386

MetLife Investment Management's DERM Position: Q1 2020 in Review

MetLife Investment Management sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 21,590 shares — an estimated $327K sold.

MetLife Investment Management first reported a position in DERM in Q4 2017 and held it in 9 quarters. The position peaked at $504K in Q4 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

MetLife Investment Management reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
MetLife Investment Management sold 21,590 Dermira, Inc. shares in Q1 2020, an estimated $327K.
MetLife Investment Management first reported a position in Dermira, Inc. in Q4 2017 and held it in 9 quarters.
MetLife Investment Management's Dermira, Inc. position peaked at $504K in Q4 2017.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on MetLife Investment Management's 13F filing for Q1 2020, filed 15 May 2020.